Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Onyx Pharmaceuticals Inc. (ONXX)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: ONXX
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Analysis - Latest Articles
by
most recent
|
most commented
13 Biotechs to Watch for at Hematology Conference
Nov 30
•
Michael Becker
•
Comment!
11 'Babies with Bathwater' and 20 'Dogs with Fleas' Stocks for the Week
Nov 16
•
J Clinton Hill
•
3 Comments
Wall Street Breakfast: Must-Know News
Nov 4
•
SA Editor Eli Hoffmann
•
14 Comments
Onyx Pharmaceuticals: Could Acquiring Proteolix Be the Deal of the Year?
Oct 22
•
Prohost Biotech
•
1 Comment
Biotech Companies Turn to Capital Markets
Oct 18
•
The Burrill Report
•
Comment!
Onyx / Proteolix: Checking the Synergy of the Acquisition
Oct 13
•
Douglas Cress
•
Comment!
Onyx to Acquire Cancer Drugmaker Proeolix
Oct 13
•
Zacks.com
•
Comment!
Weekly Street Sentiment: Sell Side Loves Everything and Everybody
Oct 13
•
First Coverage
•
3 Comments
Bayer / Onyx Cancer Drug: Possible Additional Indication Looks Promising
Sep 27
•
Zacks.com
•
Comment!
Onyx Pharmaceuticals: Nexavar Promising for Metastatic Breast Cancer
Sep 23
•
Prohost Biotech
•
1 Comment
Onyx Pharmaceuticals: Is Nexavar the Next Avastin?
Sep 22
•
Raymond Chung
•
5 Comments
Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers
Sep 20
•
Justin M. Hall
•
3 Comments
Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up
Sep 11
•
Justin M. Hall
•
23 Comments
Onyx Pharmaceuticals: Good Reasons for Raising Capital, Investors Overly Concerned
Aug 13
•
Raymond Chung
•
2 Comments
Tuesday's Options Recap
Aug 11
•
Frederic Ruffy
•
Comment!
Onyx Signaling Appetite for Deals
Aug 11
•
EP Vantage
•
3 Comments
Who Will Buy Spectrum Pharmacueticals?
Aug 6
•
Mark Cifra
•
2 Comments
Too Late to Board the Biotech Bandwagon?
Jul 28
•
Sam Subramanian
•
5 Comments
VC Financings Boost Interest in Biotech
Jul 24
•
The Burrill Report
•
Comment!
FDA Calendar Updates: Schering-Plough, Hemispherx, Bovie Medical
Jul 23
•
Mike Havrilla
•
Comment!
Pharmaceutical Dollar Rationing by Results
Jul 1
•
Michael Steinberg
•
14 Comments
Keryx: Another Beneficiary of the ASCO Effect
Jun 3
•
Michael Becker
•
5 Comments
Biotech Opportunities: Look for Decent Pipeline, Big Pharma Partnerships
Jun 2
•
Zacks.com
•
15 Comments
Big Pharma's Pheeding Phrenzy
May 28
•
Mike Huckman
•
Comment!
Pequot Capital Closes: Expect Downward Pressure on Top Holdings
May 28
•
Todd Walker
•
4 Comments
Friday's Options Recap
May 8
•
Frederic Ruffy
•
1 Comment
Pequot Capital: Yet Another Hedge Fund Buying Gold
Mar 27
•
Market Folly
•
2 Comments
Arena's Financing Deal with Azimuth Is a Healthy Move
Mar 25
•
Mark Cifra
•
10 Comments
Tudor Investment Takes New Positions in Financials, Among Others
Mar 17
•
Market Folly
•
3 Comments
Where Might Genentech Investors Redeploy $47B?
Mar 16
•
Michael Becker
•
2 Comments
China Biopharma Undergoes Systemic Changes
Jan 25
•
ChinaBio Today
•
Comment!
China Biotech Gets Off to a Slow Start for 2009
Jan 11
•
ChinaBio Today
•
Comment!
Fast Money Recap - Bullish on Biotech (1/5/09)
Jan 6
•
SA Editor Miriam Metzinger
•
Comment!
Hedge Fund Tracking: Pequot Capital Management (Art Samberg), Q3 2008
Dec 30, 2008
•
Market Folly
•
Comment!
What Are Some of the Best Hedge Fund Managers Doing?
Nov 19, 2008
•
Keith Robison
•
11 Comments
Onyx's $320M Bet on BTG's Anticancer Compound
Nov 10, 2008
•
Eben Tessari
•
Comment!
Even Fatter Yields for Pfizer; M&A Targets in the Sector
Oct 17, 2008
•
Mike Havrilla
•
3 Comments
U.K. Limits 'Quality of Life' Meds to £30,000 a Year
Oct 12, 2008
•
Michael Steinberg
•
3 Comments
41 Stocks Returning 10% or More Last Week
Aug 17, 2008
•
TraderMark
•
8 Comments
5 Potential Buyout Targets in Biotech - Barron's
Aug 17, 2008
•
SA Editor Rachael Granby
•
9 Comments
A Biotech Bloom in July
Jul 28, 2008
•
Option Dragon
•
10 Comments
1
2
3
Next Page